Chinese study: Favipiravir seems to work against Covid-19

China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the novel coronavirus disease (COVID-19), according to an official Tuesday.

Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director of the China National Center for Biotechnology Development.

A multi-centered randomized clinical study led by the Zhongnan Hospital of Wuhan University also suggested that the therapeutic effect of Favipiravir is much better than that of the control group.

Japan will provide this drug for free to 28 countries. Favipiravir is a drug from the medical daughter of Fujifilm.

sources: https://www.handelszeitung.ch/panorama/japan-liefert-covid-19-medikament-avigan-38-lander & http://www.xinhuanet.com/english/2020-03/17/c_138888102.htm

Published by verycalmcorona

Simple Belgian citizen. I am not a native english speaker.

%d bloggers like this: